Individual Study / PREVEND

Prevention of REnal and Vascular ENd-stage Disease

Prevention of REnal and Vascular ENd-stage Disease

PREVEND logo
Initiatives -
To assess the impact of elevated urinary albumin loss in non-diabetic subjects on future cardiovascular and renal disease.
Start Year
1997
End Year
2001
Supplementary Information
https://www.rug.nl/research/portal/datasets/prevention-of-renal-and-vascular-endstage-disease-prevend(59fb20f0-8121-47e8-acd4-e9c19041b950).html
Visit PREVEND

Members

Download
Investigators Contacts
  • Dr. Professor Hans Hillege
    The University Medical Center Groningen

Design

Study design
Population cohort
Follow Up
8592 subjects measured at baseline and during 5 follow-up screening rounds.
Supplementary Information
https://www.researchgate.net/figure/Flowchart-of-the-Prevention-of-Renal-and-Vascular-End-stage-Disease-PREVEND-Study_fig1_6586919

Marker Paper

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
8,592
Number of participants with biosamples
Supplementary Information
Inhabitants of the city of Groningen (age of 27 to 75 years)

Access

Availability of data and biosamples

Data
Biosamples
Other

Availability of access information

By contacting the study representative